Investors

Webcast ImageWebcast
Q3 2017 Bioverativ Inc Earnings Conference Call (Live)
10/27/17 at 8:00 a.m. ET
Q3 2017 Bioverativ Inc Earnings Conference Call
Friday, October 27, 2017 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile

Bioverativ is a global biopharmaceutical company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development and commercialization of innovative therapies. Launched in 2017 following separation from Biogen Inc., Bioverativ builds upon a strong heritage of scientific innovation and is committed to actively working with the blood disorders community. The company’s mission is to create progress for patients where they need it most, and its hemophilia therapies, when launched, represented the first major advancements in hemophilia treatment in more than two decades. For more information, visit www.bioverativ.com or follow @Bioverativ on Twitter.

 

Events and Webcasts

Q3 2017 Bioverativ Inc Earnings Conference Call
Friday, October 27, 2017 8:00 a.m. ET

IR Contact

Investor Relations
Phone: 781-663-4360
Email: IR@bioverativ.com